Poorva Bindal to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Poorva Bindal has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.616
-
Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511.
Score: 0.616